8-K 1 htm_52300.htm LIVE FILING Aspen Aerogels, Inc. (Form: 8-K)  

 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   August 10, 2015

Aspen Aerogels, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 001-36481 04-3559972
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
30 Forbes Road, Building B, Northborough, Massachusetts   01532
_________________________________
(Address of principal executive offices)
  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   (508) 691-1111

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

5.02(c). Effective August 10, 2015, Aspen Aerogels, Inc., (the "Company") has appointed Jeffrey A. Ball, age 47, as its Vice President, Operations. Mr. Ball has served as the Company's Vice President, Engineering since January 2013. Mr. Ball has over 20 years of manufacturing and engineering experience with senior positions at Genzyme, Amgen, Bayer and Rohm & Haas. Mr. Ball holds a BS in Chemical Engineering from Bucknell University and an MS in Chemical Engineering from Villanova University.






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
Date: August 14, 2015  
Aspen Aerogels, Inc.
   
By: /s/ John F. Fairbanks
                                                                                    

   
 
   
Name: John F. Fairbanks
                                                                                     

                                                                                     
Title: Vice President, Chief Financial
Officer and Treasurer